Related Experiment Video
Updated: Oct 7, 2025
10:58
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
13.1K
Glioblastomas.
Gaetano Finocchiaro1, Giulia Berzero1,2
1Neurology Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Cancers
|January 11, 2022
Summary
Glioblastoma, an aggressive brain tumor, displays significant heterogeneity. This tumor
Area of Science:
- Neuro-oncology
- Cancer biology
- Genomics
Background:
- Glioblastoma (GBM) is a highly aggressive primary brain tumor.
- The term 'multiforme' was removed from its name, despite the tumor's known heterogeneity.
- Understanding GBM's diverse characteristics is crucial for effective treatment.
Discussion:
- The extraordinary heterogeneity of glioblastoma presents significant challenges in diagnosis and treatment.
- Investigating the molecular and cellular diversity within GBM is essential.
- The term 'multiforme' accurately reflected the complex nature of this devastating disease.
Key Insights:
- Glioblastoma exhibits remarkable intratumoral and intertumoral heterogeneity.
- This heterogeneity impacts therapeutic response and patient outcomes.
- Revisiting the classification and understanding of GBM's diversity is warranted.
Outlook:
- Future research should focus on subtyping glioblastoma based on its heterogeneity.
- Developing targeted therapies that address specific GBM subtypes is a key goal.
- Personalized medicine approaches are critical for improving glioblastoma patient survival.
